Nima Farzan

Nima Farzan has served as a member of the board of directors since March 2020. Mr. Farzan is currently Chief Executive Officer and director of Kinnate Biopharma. Prior to Kinnate, Mr. Farzan served as an advisor for a number of life sciences companies. Previously, Mr. Farzan was President and Chief Executive Officer at PaxVax Corporation (acquired by Emergent Biosolutions), held positions of increasing seniority at Novartis AG and various marketing and business development positions at DoubleTwist. Mr. Farzan served as an associate at The Boston Consulting Group. He has a bachelor’s degree in Human Biology from Stanford University and an M.B.A. from the Harvard Business School.